Enovix (NASDAQ:ENVX) Cut to Underperform at Bank of America

Bank of America downgraded shares of Enovix (NASDAQ:ENVX – Free Report) from a neutral rating to an underperform rating in a report released on Wednesday, Marketbeat.com reports. The firm currently has $1.00 target price on the stock, down from their prior target price of $5.00.

Several other analysts also recently commented on ENVX. William Blair downgraded shares of Enovix from an “outperform” rating to a “market perform” rating in a research report on Monday, August 17th. Craig Hallum downgraded shares of Enovix from a “buy” rating to a “hold” rating and set a $2.00 target price for the company. in a report on Friday, November 13th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $20.00 price target on shares of Enovix in a research note on Thursday, August 13th. Northland Securities set a $4.00 price target on Enovix in a report on Tuesday, October 13th. Finally, Canaccord Genuity Group decreased their price target on Enovix to $2.50 and set a “buy” rating on the stock in a report on Monday, November 16th. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, five have assigned a Hold rating and three have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $6.95.

Get Our Latest Research Report on Enovix

Enovix Trading Down 9.7%

Enovix stock opened at $1.17 on Wednesday. The firm has a 50 day moving average of $2.11 and a 200 day moving average of $3.82. The firm has a market capitalization of $247.22 million, a price-to-earnings ratio of -1.60 and a beta of 2.34. Enovix has a 12-month low of $1.13 and a 12-month high of $9.19. The company has a current ratio of 9.10, a quick ratio of 9.37 and a debt-to-equity ratio of 3.05.

Enovix (NASDAQ:ENVX – Get Free Report) last posted its quarterly earnings results on Friday, November 13th. The company reported ($0.15) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.20) by $0.05. The business had revenue of $11.04 million during the quarter. Enovix had a negative net margin of 406.54% and a negative return on equity of 73.21%. As a group, research analysts predict that Enovix will post -0.78 earnings per share for the current year.

Institutional Investors Weigh In On Enovix

A number of institutional investors have recently added to or reduced their stakes in ENVX. BlackRock Inc. purchased a new position in Enovix during the 2nd quarter valued at approximately $100,054,000. Goldman Sachs Group Inc. increased its stake in Enovix by 22.0% in the 3rd quarter. Goldman Sachs Group Inc. now owns 2,038,868 shares of the company’s stock worth $5,913,000 after acquiring an additional 368,066 shares during the last quarter. Jump Financial LLC raised its holdings in shares of Enovix by 185.1% during the 3rd quarter. Jump Financial LLC now owns 1,596,042 shares of the company’s stock worth $4,629,000 after acquiring an additional 1,036,189 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. purchased a new stake in shares of Enovix during the 2nd quarter worth approximately $8,689,000. Finally, Bank of America Corp DE purchased a new stake in shares of Enovix during the 2nd quarter worth approximately $8,356,000. 50.92% of the stock is owned by hedge funds and other institutional investors.

Enovix Company Profile

(Get Free Report)

Enovix Corporation develops lithium-ion batteries using a silicon-based anode and a proprietary three-dimensional cell architecture. Its design is intended to increase energy density while addressing safety and performance requirements in compact devices. The company’s batteries are designed for applications including smartphones, wearable devices, laptops, augmented- and virtual-reality products, and other portable electronics. Enovix also targets markets such as defense and industrial technology.

Further Reading

Analyst Recommendations for Enovix (NASDAQ:ENVX)

Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.